Non competitive inhibitor of carbonic anhydrase?
**Core Concept**
Carbonic anhydrase is an enzyme that catalyzes the rapid conversion of carbon dioxide to bicarbonate and protons, playing a crucial role in maintaining acid-base balance and facilitating respiration in various tissues. Non-competitive inhibitors bind to an allosteric site, altering the enzyme's shape and reducing its activity without competing with the substrate for the active site.
**Why the Correct Answer is Right**
The correct answer is acetazolamide, a non-competitive inhibitor of carbonic anhydrase. It binds to the enzyme's allosteric site, inducing a conformational change that reduces the enzyme's activity. This leads to decreased production of bicarbonate and increased levels of carbon dioxide, making it useful in treating conditions like glaucoma and epilepsy.
**Why Each Wrong Option is Incorrect**
**Option A:** Sulfonamides are competitive inhibitors of dihydropteroate synthase, not carbonic anhydrase.
**Option B:** Phosphorylation is a covalent modification that activates or inhibits enzymes, but it's not a type of inhibitor.
**Option C:** Aminoglycosides are a class of antibiotics that inhibit protein synthesis by binding to the 30S ribosomal subunit, not carbonic anhydrase.
**Clinical Pearl / High-Yield Fact**
Acetazolamide is also used off-label for its diuretic effects, making it useful in managing conditions like idiopathic intracranial hypertension.
**Correct Answer:** C. Acetazolamide